Polyrizon Ltd. (PLRZ)

$1.55 -0.09 (-5.49%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 1,429,814
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza blockers. Polyrizon Ltd. was incorp...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 9 374 0120
Address:
5 Ha-Tidhar Street, Ra'anana, Israel
Schizoo
Schizoo Jun. 16 at 4:42 PM
$HCTI ❤️❤️❤️❤️ $GNLN nice job holding!! ❤️❤️❤️ $NCNA ❤️❤️❤️❤️ $PLRZ Found one.. check out the short numbers 👇👇👇👇
1 · Reply
Mack1234
Mack1234 Jun. 16 at 3:57 PM
$RGC $PTHL about to rip...., check out $PLRZ as well.
1 · Reply
Mack1234
Mack1234 Jun. 16 at 3:54 PM
$PLRZ Takeover target with $50M cash and 5m float.
0 · Reply
Schizoo
Schizoo Jun. 16 at 3:10 PM
$HCTI $GNLN $NCNA im out.. made alot and happy now.. I HOPE it continues for you all and you get rich.. im a swing trader and squeeze chaser.. Take a look at $PLRZ short number.. Be careful.. BALLS N PATIENCE
1 · Reply
Schizoo
Schizoo Jun. 16 at 3:07 PM
$GEVO bullish trend..long swing $OCGN long swing.. $AZTR this baby moves under the radar.. $ONCO beaten down.. swing this... ATL now.. rs is over.. undervalued. $PLRZ is my new short squeeze play.. take a look at the numbers.. easy hold.. long swing.. Risk reward BALLS N PATIENCE
0 · Reply
Chief84
Chief84 Jun. 16 at 2:46 PM
$PLRZ buying these cheapies
0 · Reply
Webullbro
Webullbro Jun. 16 at 2:01 PM
$PLRZ nasty news tickers.
0 · Reply
Schizoo
Schizoo Jun. 16 at 1:34 PM
$PLRZ 🤌🏼🚀🚀🤑
0 · Reply
Schizoo
Schizoo Jun. 16 at 12:53 PM
$HCTI $GNLN $NCNA $PLRZ 👇🤌🏼🚀🚀😘
1 · Reply
armanicontreras
armanicontreras Jun. 16 at 12:51 PM
$PLRZ What could send GreetEat Corporation (OTC: GEAT) higher? ➡️ Named partner announcement (Amazon? Zoom?) ➡️ Patent approval update ➡️ Platform rollout data (DAU, corporate clients) ➡️ Analyst initiations ➡️ Uplist news (OTCQB/Nasdaq ambitions?) All possible. All potential catalysts. Low-float + narrative = explosive asymmetry 💥
0 · Reply
Latest News on PLRZ
Polyrizon Reports Promising Results Demonstrating Successful Internasal Delivery of its Innovative Hydrogel Formulation for CNS Therapeutics

Jun 12, 2025, 7:32 AM EDT - 4 days ago

Polyrizon Reports Promising Results Demonstrating Successful Internasal Delivery of its Innovative Hydrogel Formulation for CNS Therapeutics

Polyrizon Announces Receipt of Nasdaq Delisting Notice

May 23, 2025, 4:15 PM EDT - 23 days ago

Polyrizon Announces Receipt of Nasdaq Delisting Notice

Polyrizon Emerges with Positive Preclinical Data on Nasal Protection Platform

May 21, 2025, 7:10 AM EDT - 26 days ago

Polyrizon Emerges with Positive Preclinical Data on Nasal Protection Platform

Polyrizon Targets $3.15B Epilepsy Market with Preclinical Studies for Innovative Rescue Treatment

May 13, 2025, 7:45 AM EDT - 4 weeks ago

Polyrizon Targets $3.15B Epilepsy Market with Preclinical Studies for Innovative Rescue Treatment

Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model

Apr 25, 2025, 7:37 AM EDT - 7 weeks ago

Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model

Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements

Apr 11, 2025, 4:15 PM EDT - 2 months ago

Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements

Polyrizon Engages Leading Branding Firm for Strategic Brand Development

Apr 2, 2025, 9:05 AM EDT - 2 months ago

Polyrizon Engages Leading Branding Firm for Strategic Brand Development

Polyrizon Ltd. Announces Closing of $17.0 Million Private Placement

Apr 1, 2025, 4:09 PM EDT - 2 months ago

Polyrizon Ltd. Announces Closing of $17.0 Million Private Placement

Polyrizon Ltd. Announces $17.0 Million Private Placement

Mar 31, 2025, 9:32 AM EDT - 2 months ago

Polyrizon Ltd. Announces $17.0 Million Private Placement

Polyrizon Structures Clinical Strategy for its Allergy Blocker Ahead of FDA Pre-Submission Meeting

Mar 27, 2025, 8:25 AM EDT - 2 months ago

Polyrizon Structures Clinical Strategy for its Allergy Blocker Ahead of FDA Pre-Submission Meeting

Polyrizon Expands Drug Delivery Innovation with Preclinical Studies for Epilepsy Rescue Treatment

Mar 25, 2025, 4:04 PM EDT - 2 months ago

Polyrizon Expands Drug Delivery Innovation with Preclinical Studies for Epilepsy Rescue Treatment

Polyrizon Signs Non– Binding LOI to Expand its Innovative Intranasal Drug Delivery Platform for Psychedelic-Based Treatments

Mar 14, 2025, 8:35 AM EDT - 3 months ago

Polyrizon Signs Non– Binding LOI to Expand its Innovative Intranasal Drug Delivery Platform for Psychedelic-Based Treatments

Polyrizon Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform

Mar 13, 2025, 7:51 AM EDT - 3 months ago

Polyrizon Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform

Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024

Mar 11, 2025, 4:27 PM EDT - 3 months ago

Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024

Polyrizon Initiates Preclinical Studies for Intranasal Naloxone Targeting Opioid Overdose Based on Its Innovative T&T Platform

Mar 10, 2025, 7:47 AM EDT - 3 months ago

Polyrizon Initiates Preclinical Studies for Intranasal Naloxone Targeting Opioid Overdose Based on Its Innovative T&T Platform

Polyrizon Announces Filing of Divisional Patent Application for Its Innovative Trap & Target™ (T&T) Intranasal Drug Delivery Platform

Jan 30, 2025, 5:55 AM EST - 4 months ago

Polyrizon Announces Filing of Divisional Patent Application for Its Innovative Trap & Target™ (T&T) Intranasal Drug Delivery Platform

Polyrizon Commences GMP Manufacturing Preliminary Process for its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial

Jan 23, 2025, 6:40 AM EST - 5 months ago

Polyrizon Commences GMP Manufacturing Preliminary Process for its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial

Polyrizon Announces Publication of U.S. National Patent Application for Its Innovative Hydrogel Nasal Technologies

Dec 30, 2024, 6:25 AM EST - 6 months ago

Polyrizon Announces Publication of U.S. National Patent Application for Its Innovative Hydrogel Nasal Technologies

Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs

Dec 19, 2024, 7:22 AM EST - 6 months ago

Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs

Polyrizon's Moving Forward with Expected 2025 Clinical Trial - Entered Manufacturing Agreement for its PL-14 Allergy Blocker

Dec 18, 2024, 6:25 AM EST - 6 months ago

Polyrizon's Moving Forward with Expected 2025 Clinical Trial - Entered Manufacturing Agreement for its PL-14 Allergy Blocker

Polyrizon Announces Appointment of VP of Regulatory Affairs and Quality Assurance

Dec 13, 2024, 6:25 AM EST - 6 months ago

Polyrizon Announces Appointment of VP of Regulatory Affairs and Quality Assurance

Polyrizon Enters into GMP Manufacturing Agreement for CTM Supply of its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial

Dec 2, 2024, 8:02 AM EST - 7 months ago

Polyrizon Enters into GMP Manufacturing Agreement for CTM Supply of its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial

Aegis Capital Corp. Acted as Sole Bookrunner on a $4.2 Million (IPO) Initial Public Offering for Polyrizon Ltd. (NASDAQ: PLRZ)

Oct 30, 2024, 1:50 PM EDT - 8 months ago

Aegis Capital Corp. Acted as Sole Bookrunner on a $4.2 Million (IPO) Initial Public Offering for Polyrizon Ltd. (NASDAQ: PLRZ)

Polyrizon Announces Closing of $4.2 Million Initial Public Offering

Oct 30, 2024, 10:28 AM EDT - 8 months ago

Polyrizon Announces Closing of $4.2 Million Initial Public Offering

Polyrizon Announces Pricing of $4.2 Million Initial Public Offering and Listing on the Nasdaq Capital Market Under New Ticker “PLRZ”

Oct 28, 2024, 7:02 PM EDT - 8 months ago

Polyrizon Announces Pricing of $4.2 Million Initial Public Offering and Listing on the Nasdaq Capital Market Under New Ticker “PLRZ”

Schizoo
Schizoo Jun. 16 at 4:42 PM
$HCTI ❤️❤️❤️❤️ $GNLN nice job holding!! ❤️❤️❤️ $NCNA ❤️❤️❤️❤️ $PLRZ Found one.. check out the short numbers 👇👇👇👇
1 · Reply
Mack1234
Mack1234 Jun. 16 at 3:57 PM
$RGC $PTHL about to rip...., check out $PLRZ as well.
1 · Reply
Mack1234
Mack1234 Jun. 16 at 3:54 PM
$PLRZ Takeover target with $50M cash and 5m float.
0 · Reply
Schizoo
Schizoo Jun. 16 at 3:10 PM
$HCTI $GNLN $NCNA im out.. made alot and happy now.. I HOPE it continues for you all and you get rich.. im a swing trader and squeeze chaser.. Take a look at $PLRZ short number.. Be careful.. BALLS N PATIENCE
1 · Reply
Schizoo
Schizoo Jun. 16 at 3:07 PM
$GEVO bullish trend..long swing $OCGN long swing.. $AZTR this baby moves under the radar.. $ONCO beaten down.. swing this... ATL now.. rs is over.. undervalued. $PLRZ is my new short squeeze play.. take a look at the numbers.. easy hold.. long swing.. Risk reward BALLS N PATIENCE
0 · Reply
Chief84
Chief84 Jun. 16 at 2:46 PM
$PLRZ buying these cheapies
0 · Reply
Webullbro
Webullbro Jun. 16 at 2:01 PM
$PLRZ nasty news tickers.
0 · Reply
Schizoo
Schizoo Jun. 16 at 1:34 PM
$PLRZ 🤌🏼🚀🚀🤑
0 · Reply
Schizoo
Schizoo Jun. 16 at 12:53 PM
$HCTI $GNLN $NCNA $PLRZ 👇🤌🏼🚀🚀😘
1 · Reply
armanicontreras
armanicontreras Jun. 16 at 12:51 PM
$PLRZ What could send GreetEat Corporation (OTC: GEAT) higher? ➡️ Named partner announcement (Amazon? Zoom?) ➡️ Patent approval update ➡️ Platform rollout data (DAU, corporate clients) ➡️ Analyst initiations ➡️ Uplist news (OTCQB/Nasdaq ambitions?) All possible. All potential catalysts. Low-float + narrative = explosive asymmetry 💥
0 · Reply
Mack1234
Mack1234 Jun. 16 at 12:38 PM
$PLRZ $2 target.
0 · Reply
Tofer85
Tofer85 Jun. 16 at 12:37 PM
$PLRZ it doesn’t show $2 🤣
0 · Reply
Mack1234
Mack1234 Jun. 16 at 12:32 PM
$PLRZ $2
0 · Reply
Mack1234
Mack1234 Jun. 16 at 12:15 PM
$PLRZ float is locked.
0 · Reply
Webullbro
Webullbro Jun. 16 at 11:41 AM
$PLRZ stop listening to these clowns
1 · Reply
Mack1234
Mack1234 Jun. 16 at 10:56 AM
$PLRZ $50M cash. 5m float...
0 · Reply
Schizoo
Schizoo Jun. 16 at 9:46 AM
$PLRZ $HCTI $GNLN $NCNA found one.. look at the shorts numbers.. 👇👇👇👇👇👇👇👇👇👇👇👇👇 $PLRZ 🤌🏼🚀🚀🚀
0 · Reply
Schizoo
Schizoo Jun. 16 at 9:19 AM
$PLRZ $OCGN $GEVO $AZTR fund one.. look at the shorts numbers.. 👇👇 $PLRZ 🤌🏼🚀😘
0 · Reply
Webullbro
Webullbro Jun. 16 at 9:06 AM
$PLRZ what a turd. Blame the news
0 · Reply
Jamedia66
Jamedia66 Jun. 16 at 8:59 AM
$NCNA and $PLRZ both very bullish
1 · Reply
Schizoo
Schizoo Jun. 16 at 6:53 AM
$PLRZ this is all u need to know! And then understand why this clown is bearish.. 0 shares to short.. no risk for RS and only way is up! 👇👇👇👇👇👇👇👇👇👇👇👇👇👇👇👇👇👇👇👇
0 · Reply
Chief84
Chief84 Jun. 16 at 4:07 AM
$PLRZ bought in Friday with a small position. Will avg down if needed but expecting a bounce at these levels
0 · Reply